APA (7th ed.) Citation

F, A., M, K., G, A., S, N., & CS, M. (2026). Association of glucagon-like peptide-1 receptor agonist use with anxiety disorders, depression, self-harm, and suicidality: A large cohort study. Diabetes research and clinical practice, 233, 113104. https://doi.org/10.1016/j.diabres.2026.113104

Chicago Style (17th ed.) Citation

F, Anagnostakis, Kokkorakis M, Anastasiou G, Nagarajan S, and Mantzoros CS. "Association of Glucagon-like Peptide-1 Receptor Agonist Use with Anxiety Disorders, Depression, Self-harm, and Suicidality: A Large Cohort Study." Diabetes Research and Clinical Practice 233 (2026): 113104. https://doi.org/10.1016/j.diabres.2026.113104.

MLA (9th ed.) Citation

F, Anagnostakis, et al. "Association of Glucagon-like Peptide-1 Receptor Agonist Use with Anxiety Disorders, Depression, Self-harm, and Suicidality: A Large Cohort Study." Diabetes Research and Clinical Practice, vol. 233, 2026, p. 113104, https://doi.org/10.1016/j.diabres.2026.113104.